- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04214379
Management of Severe Congenital Blepharoptosis
December 31, 2019 updated by: Mohamed Farag Khalil Ibrahiem, Minia University
Evaluation of Polytetrafluoroethylene (Ptose-up) in Management of Severe Congenital Blepharoptosis
Frontalis sling surgery was carried out using Ptose-up under general anaesthesia for patients with severe congenital ptosis.
Study Overview
Detailed Description
Frontalis sling surgery was carried out using Ptose-up for patients with severe congenital ptosis in 23 eyes of 15 patients and they followed up for at least 6 months to detect the success rate and if there is any postoperative complications.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minia
-
Minya, Minia, Egypt, 61111
- Faculty of medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 months to 9 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Severe congenital blepharoptosis
- Poor levator muscle function
- No previous ptosis surgery
Exclusion Criteria:
- Patients with Jaw winking phenomenon
- Blepharophimosis syndrome
- Congenital myasthenia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: severe congenital ptosis
Patients with severe congenital ptosis with poor levator muscle function
|
Frontalis sling surgery using pose-up and Wright's fascia-lata needle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement of ptosis
Time Frame: 3 months
|
The average marginal reflex distance was improved from -0.8 mm preoperative to +2.73 mm after 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2017
Primary Completion (Actual)
March 10, 2018
Study Completion (Actual)
September 17, 2018
Study Registration Dates
First Submitted
December 28, 2019
First Submitted That Met QC Criteria
December 28, 2019
First Posted (Actual)
January 2, 2020
Study Record Updates
Last Update Posted (Actual)
January 3, 2020
Last Update Submitted That Met QC Criteria
December 31, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Oculoplastic Unit
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blepharoptosis
-
RVL Pharmaceuticals, Inc.CompletedAcquired BlepharoptosisUnited States
-
Levation Pharma, Ltd.Completed
-
Skelmet IncMassachusetts Eye and Ear InfirmaryCompleted
-
RVL Pharmaceuticals, Inc.CompletedBlepharoptosisUnited States
-
CHU de Quebec-Universite LavalCompleted
-
Cairo UniversityCompleted
-
University of MiamiCompleted
-
RVL Pharmaceuticals, Inc.Completed
-
Rabin Medical CenterUnknown
Clinical Trials on Ptosis surgery
-
Ain Shams UniversityCompletedMild Ptosis | Moderate PtosisEgypt
-
University of AarhusCompletedAcute Post Operative Pain | Chronic Postsurgical PainDenmark
-
International Study Group on Minimally Invasive...Fondazione CARIT; LOGIX S.r.l.Unknown
-
Peking Union Medical College HospitalCompletedPancreatic Neuroendocrine TumorsChina
-
Hospital Central de la Defensa Gómez UllaClinica Universidad de Navarra, Universidad de NavarraEnrolling by invitationRectal Cancer | PROM | Functional Bowel DisorderSpain
-
Sunnybrook Health Sciences CentreMcMaster University; Unity Health Toronto; University of Toronto; University of... and other collaboratorsCompleted
-
Shanghai Zhongshan HospitalUnknownCarcinoma, Pancreatic Ductal | Circulating Tumor CellsChina
-
The Second Hospital of Shandong UniversityRecruitingLung Diseases | SurgeryChina
-
Federal University of São PauloUnknownObesity | LymphedemaBrazil
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruitingQuality of Life | Lung NeoplasmsUnited Kingdom